Ultherapy® Named “Best Skin Tightening Device” by The Aesthetic Guide

Merz announced today Ultherapy® has been named the “Best Skin Tightening Device” by THE Aesthetic Guide, a leading aesthetic industry publication. Ultherapy® is the only FDA- cleared, non-invasive procedure that lifts and tightens the neck, chin and brow, and improves lines and wrinkles on the chest.

THE Aesthetic Industry Awards acknowledge leaders who have developed innovative, cutting edge technologies, techniques and best practices that have been pushing the industry forward. A distinguished panel of expert judges selected top products and services in a broad range of categories.

“My patients are always looking for trusted treatments that will help them look fresher and Ultherapy continues to be a treatment I recommend because it has no downtime and delivers visible results,” said Dr. Patricia Wexler, a New York City-based cosmetic dermatologist who has treated brand ambassador Christie Brinkley with Ultherapy. “The targeted ultrasound technology makes Ultherapy a revolutionary device that allows me to customize treatments to meet the needs of my patients.”

Ultherapy® is the only cosmetic procedure to use ultrasound imaging, which allows physicians to see the layers of tissue targeted during the treatment to ensure the energy is deposited where it will be most beneficial. The unique technology is supported by more than 50 clinical studies, more than 60 published, peer-reviewed papers and over 100 patents.

“This award is a true testament to Ultherapy’s innovation and proven results,” said Bob Rhatigan, CEO of Merz North America. “Ultherapy is trusted by physicians around the world and continues to be recognized in the industry for its one-of-a-kind clinically-proven technology. We are proud to have celebrated the milestone of one million treatments with Ultherapy earlier this year and look forward to the next million.”

For more information about Ultherapy®, visit:

About Ultherapy®

As the first and only treatment FDA-cleared to non-invasively lift the eyebrow, neck and chin, and to improve lines and wrinkles on the décolletage, Ultherapy® is the only cosmetic procedure to use ultrasound imaging to target the skin’s foundational layer to lift and tighten naturally, without surgery or downtime. The most common side effects reported in clinical trials were redness, swelling, pain and transient nerve effects.

Reported adverse events from post-marketing surveillance are available in the Instructions for Use (IFU). Please see the IFU for product and safety information, including a full list of these events at

Download File:
12.04.20172 [ 0 KB ]

Press Contact

Merz North America

Emily Browder
Corporate Communications


Phone: +1 919.582.8114

Merz in the Americas

Merz has a direct presence in six countries in the Americas, as well as a network of selected professional distribution partners in South and Central America and the Caribbean. Merz in the Americas is headquartered in Raleigh, North Carolina, and has facilities in Mesa, Arizona, Franksville, Wisconsin as well as offices in Toronto, Canada, Mexico City, Bogotá, Colombia, São Paolo, Brazil and Buenos Aires, Argentina.

Merz Worldwide

With approximately 3,000 employees and a direct presence in 28 countries, Merz is a global, family-owned aesthetics and neurotoxin company based in Frankfurt, Germany. Privately held for 110 years, the company is distinguished by its commitment to innovation, long-term perspective and focus on profitable growth. In addition to its comprehensive portfolio of medical aesthetic products in the device, injectable and skincare categories, Merz also develops neurotoxin therapy to treat neurologically-induced movement disorders. In fiscal year 2016/17, Merz generated revenue of EUR 1,092.9 million. More information is available at

Media Contact – Global

Merz Pharma GmbH & Co. KGaA
Global Corporate Communications
Mariana Smith Bourland
Phone: +49 151 4249 1466

Media Contact – North America

Merz North America, Inc.
Corporate Communications
Emily Browder
Phone: +1 919.582.8114